Amanita Bisporigera ingestion: Mistaken identity, dose-related toxicity, and improvement despite severe hepatotoxicity

Pediatric Emergency Care

Volumn 22, Issue 3, 2006, Pages 177-180

  Madhok, Manu ^a,b,d   Scalzo, Anthony J ^a,b   Blume, Carolyn M ^a   Neuschwander Tetri, Brent A ^b,c   Weber, Julie A ^a,b   Thompson, Michael W ^a,b  

^a Cardinal Glennon Children's Hospital   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Saint Louis University   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Amanita mushroom poisoning; Hepatotoxity; Nasobiliary drainage; Pathophysiology and treatment

Indexed keywords

ACETYLCYSTEINE; ACTIVATED CARBON; ALANINE AMINOTRANSFERASE; ALPHA AMANITIN; AMMONIA; ASPARTATE AMINOTRANSFERASE; BETA AMANITIN; BILIRUBIN; CIMETIDINE; GAMMA GLUTAMYLTRANSFERASE; OCTREOTIDE; PENICILLIN G; SILYMARIN; SODIUM CHLORIDE; THIOCTIC ACID;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AMANITA BISPORIGERA; ARTICLE; CASE REPORT; DIARRHEA; DRAIN; EMERGENCY WARD; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL ENDOSCOPY; HEMODIALYSIS; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HUMAN; INGESTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; MUSHROOM; MUSHROOM POISONING; NASOBILIARY DRAIN; NAUSEA; PANCREATITIS; PATHOPHYSIOLOGY; PROTHROMBIN TIME; VOMITING;

ADOLESCENT; AMANITA; HEPATITIS, TOXIC; HUMANS; MALE; MUSHROOM POISONING; SEVERITY OF ILLNESS INDEX;

EID: 33646795700     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000202459.49731.33     Document Type: Article

References (24)

1. Bryson PD. Mushrooms. In: Bryson PD, ed. Comprehensive Review in Toxicology for Emergency Clinicians. 3rd ed. Washington, DC: Taylor & Francis; 1996:685-693.
2. Ellenhorn MJ. Plants-mycotoxins-mushrooms. In: Ellenhorn's Medical Toxicology. 2nd ed. Philadelphia, PA: Williams & Wilkins; 1997:1881-1896.
3. Vesconi S, Langer M, Lapichino G, et al. Therapy of cytotoxic mushroom intoxication. Crit Care Med. 1985;3:402-406.
4. Fineschi V, Di Paolo M, Centini F. Histological criteria for diagnosis of Amanita poisoning. J Forensic Sci. 1996;41:429-432.
5. Cappell MS, Hassan T. Gastrointestinal and hepatic effects of Amanita phalloides ingestion. J Clin Gastroenterol. 1992;5:225-228.
6. Castiella A, Arenas JI. Utility of silymarin in the cyclopeptide syndrome. J Hepatol. 1994;21:1148.
7. Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicol Appl Pharmacol. 1984;73:355-362.
8. Flora K, Hahn M, Rosen H, et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998;93:39-143.
9. Sabeel AI, Kurkus J, Lindholm T. Intensive hemodialysis and hemoperfusion treatment of Amanita mushroom poisoning. Mycopathologia. 1995;131:107-114.
10. Skaare VK. Mushroom poisoning: an indication for liver transplantation. J Transpl Coord. 1997;7:141-143.
11. Pinson CW, Daya MR, Benner KG, et al. Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg. 1990;159:493-499.
12. Spoerke DG, Rumack BH. Handbook of Mushroom Poisoning; Diagnosis and Treatment. 2nd ed. CRC Press, Lakewood, CO; 1994.
13. Montani S, Sinradi D, Pratico C, et al. Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning; case report on 11 patients. Arzneimittelforschung. December 1999;49(12):1044-1047.
14. Gundala S, Wells LD, Milliano MT, et al. The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin alpha-amanitin. Arch Toxicol. 2004;78:68-73.
15. Covic A, Goldsmith DJ, Gusbeth-tatomir P, et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int. 2003;23(suppl 3):21-27.
16. Scheurlen C, Spannbrrucker N, Spengler U, et al. Amanita phalloides intoxications in a family of Russian immigrants. Z Gastroenterol. 1994;32:399-404.
17. Diaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Crit Care Med. February 2005;33(2):419-426.
18. Warden CR, Benjamin DR. Acute renal failure associated with suspected Amanita smithiana mushroom ingestions: a case series. Acad Emerg Med. August 1998;5(8):808-812.
19. Mas A. Mushrooms, amatoxins and the liver. J Hepatol. 2005;42:166-169.
20. Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol. 2005;42:202-209.
21. Jaeger A, Jehl F, Flesch F, et al. Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol. 1993;31(1):63-80.
22. Brent J, Wallace KL, Burkhart KK, et al, eds. Critical Care Toxicology: Diagnosis and Management. Philadelphia, PA: Elsevier Mosby; 2005.
23. Goldfrank RL, et al, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill; 2002.
24. Kuo M. October 2003. The destroying angel: Amanita bisporigera. Available at: http://www.mushroomexpert.com/amanita_bisporigera.html. Accessed August 2005.